The smaller pharma companies I find it tough to evaluate, so many of them can potentially do well but I do not have the bandwidth to go molecule by molecule and evaluate those companies. But I think Sun Pharma is a decent business model, so we are just holding it for the long term.
5 smallcap mutual funds turn Rs 10,000 monthly SIP to over Rs 1 crore in 15 years
Five smallcap mutual funds have turned a monthly SIP of Rs 10,000 into over Rs 1 crore in the last 15 years. Notable performers include